North Carolina Pharmacist Winter Journal 2013

ting um Mee ils pg. 2 r o F e ractic , deta

Care P ter now Chronic -22, 2013. Regis arch 20 M

North Carolina

Pharmacist Vol. 93, Number 1

Advancing Pharmacy. Improving Health.

Winter 2013

It’s time to register for the

North Carolina Association of Pharmacists 2013 Chronic Care Practice Forum Meeting

March 20-22, 2013, The Ballantyne Hotel and Resort, Charlotte, NC

Featured speakers: Kelly Jones and James Cooper 15 Hours of Quality CE • Golf Tournament Exhibits & Poster Session • Networking and more!

Topics include: • A Comprehensive, Evidence-Based Review of Treating Pain and Suffering • Navigating the Regulatory Abyss: A LTC Advocacy Update • New Drug Update for Long-Term Care 2013 • You’re Only Old Once - Medical Decision-Making in the Aged • What’s New in ID: Focus on LTC/Chronic Care Setting • Assessment & Management of Common Anemias in Senior Patients • Clinical Management of Antipsychotic Therapy in the Elderly • Psychostimulant Treatment for Apathy in Patients with Dementia • Not Your Daughter’s Irritable Bowel Syndrome • Long-Term Management of Epilepsy • Revised Beer’s Criteria • Medication Reconciliation

Hotel Information: Reserve your room now, the cut-off date is February 26, 2013.

The Ballantyne Hotel and Resort, Charlotte, NC 1-888-627-8048 Group Code: NCAP or NC Association of Pharmacists Rates: $169 single and double, $189 triple, $199 quad. All rooms include complimentary wireless internet.

REGISTER NOW: https://m360.ncpharmacists.org/event.aspx?eventID=70464&instance=0

Official Journal of the North Carolina Association of Pharmacists 109 Church Street • Chapel Hill, NC 27516 800.852.7343 or 919.967.2237 fax 919.968.9430 www.ncpharmacists.org

North Carolina

Pharmacist

JOURNAL STAFF

Vol. 93, No. 1

EDITOR Sally J. Slusher

Inside

EDITORIAL ASSISTANTS Linda Goswick Teressa Horner Reavis

BOARD OF DIRECTORS PRESIDENT Mary Parker PRESIDENT-ELECT Michelle Ames PAST PRESIDENT Jennifer Askew Buxton TREASURER Dennis Williams BOARD MEMBERS Randy Angel Andy Bowman Jennifer Burch Jenna Ivey Burkhart Valerie Clinard Thomas D’Andrea Stephen Dedrick Leigh Foushee Alyce Holmes Debra Kemp LeAnne Kennedy Kimberly Lewis Natasha Michaels North Carolina Pharmacist (ISSN 0528-1725) is the official journal of the North Carolina Association of Pharmacists. An electronic version is published quarterly at 109 Church St., Chapel Hill, NC 27516.

The journal is provided to NCAP members through allocation of annual dues. Subscription rate to nonmembers is $40.00. annually. Opinions expressed in North Carolina Pharmacist are not necessarily official positions or policies of the Association. Publication of an advertisement does not represent an endorsement.

Nothing in this publication may be reproduced in any manner, either whole or in part, without specific written permission of the publisher.

Winter 2013

• From the President ........................................................ 4 • Pharmacy Day in the Legislature ................................... 5 • NCAP Board Orientation................................................. 6 • AENC Reception............................................................. 9 • New Practitioner Network:

Update on Strategic Projects ................................... 10

• NPN Spotlight............................................................... 10 • Candidates Sought for Election, Awards....................... 13 • Safety Solutions:

Pharmacy and Pharmacovigilance................. 14

• 2012 NCAP President’s Club........................................ 17 • Pharmacy Time Capsules............................................. 18 • Calendar of Events....................................................... 18

Is your membership up to date?

If not, you could be missing out on our many member benefits.

Don’t get left behind, renew today!

North Carolina Pharmacist, Winter 2013 3

North Carolina Association of Pharmacists 109 Church Street Chapel Hill, NC 27516 phone: 919.967.2237 • fax: 919.968.9430

Where is your home in NCAP? Dear Members, I was surprised to learn that over half of our active membership do not designate a Practice Forum with their membership renewal each year. To me, this represents a huge opportunity to increase the value of membership for our members… if our organization is able to deliver the type and kind of needed information for each pharmacist at key points in time, then we meet our goal to increase service and advocacy to pharmacists throughout the state. And so, our theme this year is simple: “Find your home in NCAP.” Throughout this year’s journal, each of our three Practice Forums and our New Practitioner Network will feature key activities and opportunities for collaboration and learning. Our goal is to raise awareness of all the different things that are happening in our organization so that you can make an informed choice of where and when to increase your involvement.

As we look into 2013, we have many energizing activities on the way such as the Chronic Care Practice Forum meeting in March which has 15 hours of continuing education available for attendees.

Special thanks to Jena Ivey Burkhart, Michelle Ames and the planning committee for putting together what appears to be an amazing two day event!

Please mark your calendar TODAY for March 26th, Pharmacy Day in the Legislature. We have several opportunities to collaborate with our pharmacy and medical colleagues for the benefit of our patients. Our program will provide two hours ACPE continuing education credit in addition to opportunities to meet with your legislators and others throughout this special day.

I must also thank the other members of my Executive Committee: Jennifer Askew, Michelle Ames, and Dennis Williams, for their assistance in providing oversight to our organizations’ day-to-day activities while we complete an Executive Director search. These folks, in conjunction with our extremely capable staff, are making this transition as seamless as can be expected.

Sincerely, Mary Parker, PharmD, BCPS President mary.h.parker@gmail.com Advancing Pharmacy. Improving Health.

4 North Carolina Pharmacist, Winter 2013

The North Carolina Association of Pharmacists presents

Pharmacy Day in the Legislature March 26, 2013, Raleigh, NC Sponsored by Association of Community Pharmacists North Carolina Association of Pharmacists North Carolina Retail Merchants Association

Take this opportunity to talk with your Legislators about important pharmacy issues.

8:00 am - 12:00 noon

Registration in Legislative Building

9:00 am - 12:00 noon

Demonstration of Pharmacist Services

12:00 noon - 2:30 pm

Visit Legislators (schedule lunch with them if possible)

2:00 pm - 2:30 pm

Registration re-opens at NC Museum of History

2:30 pm - 4:30 pm

CE Program at the NC Museum of History:

“New Drugs - 2012” and “Legislative Update”

This program provides 2 hours of ACPE approved Continuing Education.

4:30 - 5:30 pm 5:30 pm - 7:00 pm

Visit with Legislators Reception, NC Museum of History Lobby (heavy hors d’oeuvres)

All legislators will be invited.

More information and registration is available at

https://m360.ncpharmacists.org/event.aspx?eventID=72040&instance=0

NCAP Board of Directors Inaugural Meeting and Orientation The NCAP Board of Directors’ first meeting of 2013 was held January 24 at the Institute of Pharmacy in Chapel Hill. President Mary Parker presided and the business meeting was followed by an afternoon orientation for new Board members. Approved meeting minutes and meeting dates can be found on the NCAP website.

Division of Display Options, Inc. Assisting Pharmacists since 1973 Rx Planning Specialists Craig Ashton • Roland Thomas 70 years combined experience in over 2,000 pharmacies.

Compounding Labs Pharmacy Planning & Design Patient Consultation Areas Merchandising Stocking Lozier Distributor Retail and Pharmacy Fixtures Custom Wood Work Professional Installation and Delivery

9517 Monroe Road, Suite A • Charlotte, NC 28270

1-800-321-4344 www.displayoptions.com

6 North Carolina Pharmacist, Winter 2013

North Carolina Pharmacist, Winter 2013 7

8 North Carolina Pharmacist, Winter 2013

NCAP Co-sponsors 2013 AENC Legislative Reception Several members of NCAP attended a Legislative Reception to honor members of the 2013 General Assembly. The event, sponsored by the Association Executives of North Carolina, was held January 30 at the NC Museum of Natural Sciences in Raleigh. Pictured above, NCAP member Ashley Branham, Charles Rhodes representing the NC Academy of Family Physicians, and NCAP Treasurer Dennis Williams.

North Carolina Pharmacist, Winter 2013 9

New Practitioner Network

Update on Strategic Projects

By Kira Harris, PharmD, BCPS, Kimberly Lewis, PharmD, CACP, BCACP and Minal Patel, PharmD, BCPS

Throughout 2012, the NCAP New Practitioner Network (NPN) continued efforts on five main strategic projects from 2011. These projects, membership/outreach, legislative advocacy, CE programming, social networking, and research collaboration, were chosen based on NCAP’s three-year strategic plan and a special charge from the NCAP Board of Directors.

Membership and outreach has consistently been a focus of the NPN. Again this year, NPN members delivered presentations at each of the three schools of pharmacy, including interview workshops, panel discussions regarding career experiences, and organizational fairs. For residents, the committee has continued to update and distribute handouts of tidbits and clinical pearls for preparation for the Southeastern Residency Conference and the ASHP Midyear Clinical Meeting. The committee has also worked to update an informational handout on NPN to describe the benefits of becoming a member of NPN and NCAP in an effort to maintain NCAP membership following students’ graduations.

The legislative advocacy group focused most of its efforts on support-

ing bill S246 to expand the immunizing capabilities of pharmacists. This group distributed an email and talking points related to the bill to new practitioners.

This was a concerted effort with the Government Affairs Committee to unify pharmacists in the state to support the expansion of the pharmacist’s role in the community.

The NPN has continued to focus on providing education pertinent to the needs of new practitioners. This year, there was new practitioner presence at the three Practice Forum meetings as well as the annual meeting. At the Annual Convention, the NPN sponsored two concurrent sessions for new practitioners including a panel discussion on the role of pharmacists as providers and evolving pharmacy practices. In addition, the NPN sponsored two concurrent sessions on interview skills and midyear preparation for student pharmacists.

With a greater focus on communication and the emerging use of social media, the NCAP Board of Directors charged the NPN Executive Committee to develop a recommendation for the best method for communicating with NCAP members across the state. The NPN conducted a survey of the NCAP membership to determine the most widely used social media and networking sites

and their preferences regarding type and frequency of professional communications. The results of the survey will help guide the effective exchange of information related to legislative advocacy needs, opportunities for involvement and other important association information.

The NPN had identified research as an area of interest among new practitioners. A survey at the beginning of 2012 revealed the top two needs related to research were resources on preparing a manuscript and selecting an appropriate journal for publication. Resources for these areas were gathered and will be available for NCAP members soon. A summary of these resources was published in the Fall 2012 issue of North Carolina Pharmacist.

The New Practitioner Network continues to serve the profession and meet the needs of new practitioners in our state. With the appointment of new executive committee members, the NPN is excited about beginning their work for 2013. If you have identified an unmet need of new practitioners or would like to participate in the NPN efforts, please do not hesitate to contact a member of the Executive Committee.

More information can be found at http:// ncpharmacists.org/displaycommon. cfm?an=1&subarticlenbr=160 v

New Practitioner Spotlight: Leigh Ann Anderson Peek Leigh Ann Anderson Peek, PharmD, BCPS is a Pediatric Pharmacist at Wake Forest Baptist Medical Center (WFBMC), Brenner Children’s Hospital, in Winston-Salem, NC. After earning her PharmD degree from the University of Oklahoma in 2009, she completed a PGY-1 Pharmacy Practice Residency at WFBMC. In 2010, she became the first PGY-2 Pediatric Specialty Resident at WFBMC and also served as Chief Resident.

Upon residency completion, she accepted a position as a Pediatric Pharmacist at WFBMC. In this role, she exercises her passion for advocating for children’s healthcare needs, promoting pediatric medication safety, and providing education to hospitalized children and their parents. She also enjoys serving as a preceptor for pharmacy students and residents as well as teaching in the Wake Forest Physician’s Assistant program. As a former resident, Leigh helped establish Wake Forest’s teaching certificate program for pharmacy residents, and she continues her involvement as Chair of the committee.

Of all the great professional opportunities since moving to North Carolina, Leigh values NCAP as one of the most important. This organization has been instrumental in providing up to date information on crucial pharmacy legislature, patient care opportunities, and networking opportunities with other pharmacists from various practice settings around the state. As an “outsider” moving here from Oklahoma, NCAP provided a wonderful forum for her to become integrated into the North Carolina pharmacy family. She was recently honored to be elected to the NCAP Acute Care Forum’s Executive Committee for 2013, and she looks forward to building more relationships while serving in this role. She feels that, “There has never been a more crucial time to get involved in our state pharmacy organization. As pharmacists from all different areas of practice, we have the chance to stand as one body and advocate for our patients and for our profession.”

10 North Carolina Pharmacist, Winter 2013

North Carolina Pharmacist, Winter 2013 11

12 North Carolina Pharmacist, Winter 2013

Candidates Sought for NCAP Election, Awards Election

his/her specific identification as a pharmacist, reflects well on the profession.

Deadline: April 1, 2013 NCAP members interested in serving on the NCAP Board Directors/Practice Forum Executive Committees are invited to submit their bios for consideration.

Cardinal Health Foundation Rx Champions Award This award recognizes a pharmacist for his/her work within the pharmacy community to raise awareness of the serious public health problem of prescription drug abuse.

NCAP Board of Directors NCAP will elect a President-Elect (to serve as President in 2015, 3-year term) and three at-large Board Members (3-year terms).

Please send your bio to Jennifer Buxton, Past President of NCAP and Chair of the Nominating Committee, jbuxtonunc@gmail. com.

Don Blanton Award Presented to the pharmacist who has contributed the most to the advancement of pharmacy in North Carolina during the past year.

This award was established by Charles Blanton in memory of his father, Don Blanton, who served the North Carolina Pharmaceutical Association as President 1957-58.

Acute Care Practice Forum The Practice Forum will elect a Chair-Elect (3-year term), three Executive Committee members (3-year term) and one Delegate to ASHP (3-year terms). Please send your bio to Alyce Holmes, Chair of the Practice Forum, Alyce.Holmes@harnetthealth.org.

Excellence in Innovation Award (sponsored by Upsher-Smith Laboratories) Presented to a pharmacist practicing in North Carolina who has demonstrated Innovative Pharmacy Practice resulting in improved patient care.

Chronic Care Practice Forum The Practice Forum will elect a Chair-Elect (3-year term) and three Executive Committee members (3-year terms). Please send your bio to Jena Ivey Burkhart, Chair of the Practice Forum, ivey@unc.edu.

Distinguished Young Pharmacist Award (sponsored by Pharmacists Mutual Companies) Criteria for this award are: (1) Entry degree in pharmacy received less than 10 years ago (2003 or later graduation date); (2) Licensed to practice pharmacy in NC; (3) Actively practices retail, institutional, managed care or consulting pharmacy; (4) Participates in national pharmacy associations, professional programs, state association activities and/or community service.

Please send nominations for this award to Kimberly Lewis, Chair of the New Practitioner Network, kimberly.lewis@sr-ahec.org.

Community Care Practice Forum The Practice Forum will elect a Chair-Elect (3-year term) and two Executive Committee members (3-year terms). Please send you bio to Tasha Michaels, Chair of the Practice Forum, tmichaels@kerrdrug.com.

Awards Deadline for Nominations: June 3, 2013 It is a privilege for the North Carolina Association of Pharmacists to recognize excellence within the profession. NCAP members are invited to nominate deserving members for the following awards to be presented at the Convention October 20-22 in Raleigh. Nominations must be in writing (see nominations form on the website or you may request one from Linda Goswick). Send nominations to the NCAP Awards Committee, c/o Linda Goswick, 109 Church Street, Chapel Hill, NC 27516, fax to 919-9689430 or e-mail linda@ncpharmacists.org.

Bowl of Hygeia Award (sponsored by American Pharmacists Association Foundation and National Alliance of State Pharmacy Associations) Criteria for this award are: (1) Licensed to practice pharmacy in NC; (2) Has not previously received the Award; (3) Is not currently serving nor has he/she served within the immediate past two years on its awards committee or as an officer of the Association in other than an ex officio capacity; (4) Has compiled an outstanding record of community service, which, apart from

e-Prescribing PEER Portal is open for business!

The Pharmacy and Provider e-Prescribing Experience Reporting Portal and instructions on how to report can be found at: https://www.pqc.net/eprescribe Help us save lives‌ Report eRx problems TODAY! North Carolina Pharmacist, Winter 2013 13

Safety Solutions

Pharmacists and Pharmacovigilance

By Thomas Winkler, PharmD Pharmacist Case Manager Drug Safety Alliance

Ask a group of pharmacists the definition of pharmacovigilance, and you’ll probably get a bunch of different answers, maybe even a few blank stares. It’s a term that’s rarely, if ever, encountered during pharmacy school, and only maybe comes up here and there in the community or hospital setting. Simply put, pharmacovigilance is the art and science of gathering, analyzing, and databasing adverse drug events that occur during drug development and after it is approved by the FDA and marketed. The post-marketing oversight by the FDA is an important component along with the initial authorization to market a drug, and is required of both branded and generic drug manufacturers.

It is estimated that just 1 to 10% of all adverse events are reported. A case of Stevens-Johnson syndrome that develops subsequent to Bactrim use is far more likely to be reported than say, a transient headache that happens during use of xylometazoline nasal spray. However, reports of adverse events have increased significantly and consistently in recent years, from around 200,000 in 2001 to just over 900,000 in 2012. Just 5% of all go directly to the FDA, directly from individuals. The majority are submitted by drug manufac-

14 North Carolina Pharmacist, Winter 2013

turers, who gather reports from providers, patients, and others.

There are three main categories of reports: spontaneous, where a patient, a friend or family member, or a health care professional contacts the drug manufacturer; solicited, where the drug manufacturer actively reaches out to patients or providers to learn of any adverse drug effects; and finally literature reports, where in-depth cases of adverse events are published.

The nature or seriousness of the event then determines the timeframe in which the drug manufacturer is required to report it to the FDA. A serious event is one that results in death, is life-threatening, requires hospitalization or prolongs hospitalization, results in a significant disability/ incapacity, a birth defect, or is medically significant. Medically significant is a broad and encompassing term, and is based on professional judgment. Cases involving a patient death or life-threatening situations are required to be reported within 7 days.

Other cases involving medically significant events, such as hallucination, or an event which requires medical intervention, must be reported within 15 days. Finally, cases of non-serious events, such as diarrhea, rash, and others must be reported within 20 days. Depending on the nature of the event, the manufacturer may try to gather additional information, beyond that which is contained in the initial report.

For reporting purposes, any adverse event that occurs after the start of product is suspected to be caused by the product.

This is a very conservative approach. Con-

sider the case of an elderly patient who has used an OTC lotion for years to treat her dry skin and then is diagnosed with high blood pressure. Well, as implausible as it may first sound, this lotion is considered suspected, for reporting purposes, in causing her high blood pressure. By collecting and analyzing lots of reports, as well as examining biological plausibility, drug manufacturers can assess trends in adverse events and assess which ones are likely or unlikely to be caused by a given drug.

What exactly is reported? Drug manufacturers gather as much information as they can about the adverse event, including patient information such as age, concurrent medical conditions and drugs; the nature of the event, including whether or not it is labeled (expected) or unlabeled (unexpected) when compared with the product labeling; what action, if any, was taken as a result of the event (eg, drug discontinued, or intervention required such as a therapeutic procedure or drug treatment), and the outcome of the event (such as event unchanged, complete recovery, or unknown).

In compiling reports of adverse events, drug manufacturers and the FDA have to ensure consistency in how the cases are processed and databased—that is, a common reporting language must be used. In this way, reports can be standardized to facilitate retrieval and analysis. Additionally, drug manufacturers develop protocols that ensure events are handled consistently, how to properly code and database a report of someone smoking while using nicotine replacement therapy, and whether to consider a report of a patient’s scopolamine patch not sticking an adverse event or a product quality complaint. (Product quality complaints are a different area and will not be discussed here.)

So how has adverse event reporting changed over time? For most of the FDA’s existence, the only action they could take in addressing safety concerns about a drug was to remove its authorization to be marketed, a process that was often protracted and uncertain, fought long and hard by drug manufacturers. But starting in 2007, Congress authorized the agency

to work with drug manufacturers to revise labeling, restrict prescribing or distribution, or require post-marketing studies to further ensure safety of the drug. Not only does the FDA require manufacturers to report individual cases of adverse events, manufacturers are also required to make aggregate reports of safety concerns with their drugs. The timeline for aggregate reports also vary depending on the drug, and this reporting has evolved over time. For a number of years, aggregate reporting was a “data dump,� sending the FDA reams of reports. But recently, these aggregate repots have become thoughtful and critical, with manufacturers now required to take a hard look at the risk/benefit profile of the drug.

In doing so, manufacturers must examine whether or not their product continues to have a justifiable presence in the market.

The greatest changes to the field of pharmacovigilance in recent years have come from the European Union. EU countries have banded together to harmonize their reporting requirements, and have made these requirements quite stringent. The drug safety field is truly a global one, and it is likely that in coming years the FDA will adopt increasingly strict reporting requirements as well.

What is the role of pharmacists here?

Although pharmacists are only required to report deaths to the state Board of Pharmacy, we have a professional obligation to report adverse events to drug manufacturers or to the FDA directly. The quality of the reports that come in are directly tied to the value of reports coming out. Often times, reports received from patients or family members are incomplete. However,

pharmacists obviously have greater drug knowledge and are in better position to give detailed reports to manufacturers.

As more drugs enter the market with a narrow risk/benefit profile and are required by the FDA to have post-marketing safety studies, the need for quality adverse event reports will only continue to grow. It is essential that pharmacists provide reports of potential adverse events they encounter, particularly events that are unexpected.

An unusual case of angioedema that starts after a hospitalized patient starts a novel chemotherapeutic may not seem like much by itself. But by reporting this event to the manufacturer, it can be analyzed with any similar reports and any trends can then be elucidated. Quite simply, pharmacists have a duty to their patients to ensure adverse events are reported. v

NCAP has partnered with the Connecticut Pharmacy Association to offer The Pharmacist Refresher Course, an Online online course designed for pharmacists who wish to return Offerings: to community pharmacy practice after an absence from practice for three or more years. The course consists of Pharmacist three modules, all of which have been approved for ACPE Refresher credits. The first two modules are online and composed of Course weekly study segments that allow course participants to & QA/Law work at their own pace, on their own time.

The third module consists of a three-week, 90-hour live experience in a community pharmacy. Only those who participate in all three modules will earn a Pharmacist Refresher Course Certificate from Charter Oak State College. Those taking modules One and/or Two for personal enrichment will earn ACPE credits through CPA. This course will give home study law credit to any pharmacist wanting to learn about quality assurance strategies and North Carolina’s pharmacy laws.The QA/Law Course can be used to prepare for reciprocity into North Carolina, or for those who want an update on Pharmacy Law and Quality Assurance. Students must follow a two-week course schedule.

Online discussion boards and instructor monitoring and interaction keep you on track throughout the course. The course is offered the first two full weeks of every month. This course is accredited by ACPE for 15 hours of home study law education.

For more information visit www.ncpharmacists.org North Carolina Pharmacist, Winter 2013 15

16 North Carolina Pharmacist, Winter 2013

2012 NCAP President’s Club The North Carolina Association of Pharmacists and the NCPhA Endowment Fund wish to thank the following for their support in 2012. If you wish to make a tax-deductible contribution, you may do so on your membership renewal form, on the website (under Endowment Fund) or by mailing your contribution to the NCPhA Endowment Fund, 109 Church Street, Chapel Hill, NC 27516.

Platinum ($1,000 + )

J. Davie Waggett, Wilmington, NC

Judith Jones Turnage, Charlotte, NC Abbie C. Williamson, Raleigh, NC

Gold ($100 - $999)

Silver (up to $99)

Lynn Alexander, Durham, NC Randall Angel, Raleigh, NC Vestal Irving Boyles, Statesville, NC Robert Lee Carr, Rose Hill, NC David Catalano, Holly Springs, NC Robert M. Cisneros, Jr., Buies Creek, NC Cleveland Co. Pharmaceutical Association, In memory of N. A. Smith and Sherwood Tate Samy Elsherbini, Harrisburg, NC Mary Ledbetter Fischer, Shallotte, NC Stephen W. Fuller, Salisbury, NC James Furman, Boone, NC Lisa Dawn Hampton, Asheboro, NC Paul Matthew Hetrick, Raleigh, NC Samuel F. Lewis, Rockingham, NC David S. Line, Charlotte, NC Fred F. Martin, Jr., Banner Elk, NC David S. McSwain, Gastonia, NC Tom S. Miya, Omaha, Nebraska Eric D. Montijo, Durham, NC Donna Roberts Rice, Wilmington, NC Penny Shelton, Raleigh, NC P. David Smith, Burlington, NC Annette Simpson Taylor, Wallace, NC

Abisoye Adenola, Raleigh, NC George Sprite Barbee, Raeford, NC Samir Bhagat, Greensboro, NC Stephen Wayne Cagle, Charleston, SC Leslie Gordon Collins, Wilmington, NC Steven Detter, Burlington, NC Jeff Eudy, Statesville, NC Keith Norman Fulbright, Greensboro, NC William Augustus Hodges, Greensboro, NC J. Winston Hollingsworth, Rich Square, NC LeAnne Davidson Kennedy, Winston-Salem, NC George Fred Kirkpatrick, Jr., Winchester, VA Jennifer Cavanaugh Knowles, Wallace, NC Timothy Victor Marcham, Aberdeen, NC Elizabeth Jennings Martin, Clemmons, NC Michael Douglas Martz, Durham, NC Melody Inga Milroy, Charlotte, NC Mary S. Morgan, Buxton, NC Connie Daughtry Nance, Cary, NC Wallace H. Plyler, Concord, NC Denise H. Rhoney, Chapel Hill, NC William T. Rhodes III, Lumberton, NC Ronald Jackson Winstead, Emerald Isle, NC

North Carolina Pharmacist, Winter 2013 17

Pharmacy Time Capsules

By Dennis B. Worthen, Lloyd Scholar, Lloyd Library and Museum, Cincinnati, OH 1988 - Twenty-five years ago: • Medicare Catastrophic Health Care Act passed by Congress but repealed immediately after outcry by a groundswell of negative reactions.

• Board of Pharmacy Specialties (BPS) recognizes Pharmacotherapy and Nutritional support as pharmacy practice specialties.

1963 - Fifty years ago: • The first measles vaccine was licensed for use in the U.S. John Enders developed the vaccine from a strain of measles isolated by Thomas Peebles.

• Valium (diazepam) was marketed by Hoffman-LaRoche.

1938 - Seventy-fiveyears ago: • The Federal Food, Drug, and Cosmetic Act was passed in response to deaths from the use of Massengill’s Elixir of Sulfanilamide.

• Albert Hofmann of Sandoz Laboratories in Switzerland synthesized LSD (lysergic acid diethylamide).

1913 - One hundred years ago: • Alaska passed territorial practice act.

calendar February 23, 2013 Technician Review Seminar Raleigh, NC February 24, 2013 Technician Review Seminar Greensboro, NC March 9, 2013 Technician Review Seminar Hickory, NC March 10, 2013 Technician Review Seminar Charlotte, NC March 20-22, 2013 Chronic Care Practice Forum Meeting The Ballantyne Hotel, Charlotte, NC March 26, 2013 Pharmacy Day in the Legislature Raleigh, NC

1888 - One hundred twenty-five years ago: • First class of pharmacy students enrolled in the South Dakota State College (then the State Agricultural College) in Brookings, SD. One of a series contributed by the American Institute of the History of Pharmacy, a unique non-profit society dedicated to assuring that the contributions of your profession endure as a part of America’s history. Membership offers the satisfaction of helping continue this work on behalf of pharmacy, and brings five or more historical publications to your door each year. To learn more, check out: www.aihp.org 18 North Carolina Pharmacist, Winter 2013

July 12, 2013 Residency Conference Sheraton Four Seasons, Greensboro NC October 20-22, 2013 NCAP Annual Convention Raleigh Convention Center For more information visit www.ncpharmacists.org

North Carolina Pharmacist, Winter 2013 19

NCAP has partnered with Konvoke, Inc. to create a new member benefit to support the awareness and growth of our association. We’re helping pharmacists like you make informed buying decisions about healthcare products and services by connecting you with others who have already made these decisions.

You now have free access to www.konvoke.com, an online forum where you can find unbiased advice through peer written product reviews. More importantly, you can assist your colleagues by providing feedback and writing your own product reviews. Review content on Konvoke is exclusive to healthcare based professionals and is 100% confidential.

As a result of this partnership, NCAP will receive revenue each time you write a product review. Your reviews will help your colleagues make great purchasing decisions and help NCAP generate funds so we can better serve your needs. It’s a win-win for everyone! Should you choose to not participate, you may easily opt out at any time.

Members of several other state pharmacy associations are taking advantage of this great benefit. We hope you are too.

Please remember to Konvoke before you buy! www.konvoke.com

20 North Carolina Pharmacist, Winter 2013

NCAP’s Technician Review Seminar will help you prepare for the PTCB Exam. Check www.ncpharmacists.org for Seminar dates and locations.

North Carolina Pharmacist, Winter 2013 21

22 North Carolina Pharmacist, Winter 2013